Stem Cell Modelling in COVID-19
Rajeev Nagpal *
Brandeis University, Boston, Massachusetts, USA.
Akriti Srivastava
University of Connecticut Health Centre, Farmington, Connecticut, USA.
Victor Ekuta
Massachusetts Institute of Technology, Boston, USA.
*Author to whom correspondence should be addressed.
Abstract
The ability of stem cells to differentiate into any desired cell type can make them an indispensable tool in COVID-19 modelling studies. Stem cells derived from patients with preexisting conditions or derived from vulnerable populations such as children, can also assist scientists in understanding the unique contributions of these diverse factors to variations in COVID-19 infection responses. Innovative approaches are urgently needed to adequately address the global impact of COVID-19. Stem cell based strategies offer such an approach.
Keywords: Stem cell, modelling, COVID-19.